Celgene Reports Fourth Quarter and Full Year 2015 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Jefferies Cuts Price Target on Celgene (CELG) as FX Weighs on Near-Term
January 29, 2016 9:07 AM ESTJefferies maintained a Buy rating on Celgene (NASDAQ: CELG), and cut the price target to $146.00 (from $149.00), following the company's 4Q earnings report. FX volatility appears to be weighing a bit on near-term performance prospects. CELG noted that the ~$700-800M negative top-line impact... More
Celgene (CELG) Misses Q4 EPS by 4c
January 28, 2016 7:32 AM ESTCelgene (NASDAQ: CELG) reported Q4 EPS of $1.18, $0.04 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $2.54 billion versus the consensus estimate of $2.54 billion.
GUIDANCE:
Celgene sees Q1 2016 EPS of $1.27-$1.30, versus the consensus of... More
